Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

FDA approves Neuraceq for PET imaging of beta-amyloid neuritic plaque density

March 21, 2014

Navidea Biopharmaceuticals discusses Lymphoseek MAA with EMA committee

March 20, 2014

Trovagene introduces NGS-based KRAS oncogene mutation assay

March 19, 2014

Fujifilm initiates Japanese phase I study of a radiopharmaceutical diagnostic for prostate cancer

March 17, 2014

Ventana Medical Systems and Bayer extend companion diagnostics collaboration

March 13, 2014

Cytox initiates clinical trials of mTOR blood tests for dementia

March 10, 2014

FDA accepts additional Lymphoseek supplemental NDA for review

March 6, 2014

Cellectar Biosciences begins phase II imaging trial of [124I]CLR-1404

March 6, 2014

QIAGEN launches careHPV Test in India

Feb. 28, 2014

NeuraCeq obtains E.U. approval for PET imaging of beta-amyloid neuritic plaque density

Feb. 25, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.